Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma

Massimo Mannelli, M. L. De Feo, M. Maggi, C. Pupilli, G. Opocher, T. Valenza, E. Baldi, M. Serio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In the present paper we report our experience on the utility of basal plasma catecholamine (CA) measurement and of the clonidine-suppression test in the diagnosis of pheochromocytoma. Basal noradrenaline (NA) and adrenaline (A) were assayed in plasma samples of 27 subjects affected by pheochromocytoma. When compared to basal values obtained in hypertensive patients without pheochromocytoma, one or both the CA resulted pathologically elevated in all patients except one. The response to the clonidine-suppression test was evaluated in 41 hypertensive patients suspected of having a pheochromocytoma measuring plasma NA and A in basal conditions and 2 and 3 h after oral administration of 300 μg clonidine. Extensive laboratory and instrumental findings confirmed the presence of pheochromocytoma only in 12 patients. Among the other 29 patients basal plasma CA resulted higher than normal in 4 patients. In patients without pheochromocytoma clonidine induced a significant fall in both NA and A plasma levels. The decrease in NA was observed in each patient. The 12 patients with pheochromocytoma showed a pathological elevation of one or both the CA. In this group clonidine did not significantly suppress plasma CA. The individual responses were extremely variable. Our data confirm the validity of plasma CA measurement as a diagnostic tool for the diagnosis of pheochromocytoma. The results of the clonidine-suppression test were generally confirmatory of the basal CA plasma values but in the 4 hypertensive patients without pheochromocytoma who showed basal plasma CA higher than normal clonidine resulted a useful tool in excluding the presence of pheochromocytoma.

Original languageEnglish
Pages (from-to)377-382
Number of pages6
JournalJournal of Endocrinological Investigation
Volume10
Issue number4
DOIs
Publication statusPublished - 1987

Fingerprint

Clonidine
Pheochromocytoma
Catecholamines
Norepinephrine
Epinephrine
Oral Administration

Keywords

  • clonidine-suppression test
  • Pheochromocytoma
  • plasma catecholamines
  • urinary vanillylmandelic acid

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. / Mannelli, Massimo; De Feo, M. L.; Maggi, M.; Pupilli, C.; Opocher, G.; Valenza, T.; Baldi, E.; Serio, M.

In: Journal of Endocrinological Investigation, Vol. 10, No. 4, 1987, p. 377-382.

Research output: Contribution to journalArticle

Mannelli, Massimo ; De Feo, M. L. ; Maggi, M. ; Pupilli, C. ; Opocher, G. ; Valenza, T. ; Baldi, E. ; Serio, M. / Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. In: Journal of Endocrinological Investigation. 1987 ; Vol. 10, No. 4. pp. 377-382.
@article{7ed7bc72010f4a06bab59718e54e8418,
title = "Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma",
abstract = "In the present paper we report our experience on the utility of basal plasma catecholamine (CA) measurement and of the clonidine-suppression test in the diagnosis of pheochromocytoma. Basal noradrenaline (NA) and adrenaline (A) were assayed in plasma samples of 27 subjects affected by pheochromocytoma. When compared to basal values obtained in hypertensive patients without pheochromocytoma, one or both the CA resulted pathologically elevated in all patients except one. The response to the clonidine-suppression test was evaluated in 41 hypertensive patients suspected of having a pheochromocytoma measuring plasma NA and A in basal conditions and 2 and 3 h after oral administration of 300 μg clonidine. Extensive laboratory and instrumental findings confirmed the presence of pheochromocytoma only in 12 patients. Among the other 29 patients basal plasma CA resulted higher than normal in 4 patients. In patients without pheochromocytoma clonidine induced a significant fall in both NA and A plasma levels. The decrease in NA was observed in each patient. The 12 patients with pheochromocytoma showed a pathological elevation of one or both the CA. In this group clonidine did not significantly suppress plasma CA. The individual responses were extremely variable. Our data confirm the validity of plasma CA measurement as a diagnostic tool for the diagnosis of pheochromocytoma. The results of the clonidine-suppression test were generally confirmatory of the basal CA plasma values but in the 4 hypertensive patients without pheochromocytoma who showed basal plasma CA higher than normal clonidine resulted a useful tool in excluding the presence of pheochromocytoma.",
keywords = "clonidine-suppression test, Pheochromocytoma, plasma catecholamines, urinary vanillylmandelic acid",
author = "Massimo Mannelli and {De Feo}, {M. L.} and M. Maggi and C. Pupilli and G. Opocher and T. Valenza and E. Baldi and M. Serio",
year = "1987",
doi = "10.1007/BF03348153",
language = "English",
volume = "10",
pages = "377--382",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "4",

}

TY - JOUR

T1 - Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma

AU - Mannelli, Massimo

AU - De Feo, M. L.

AU - Maggi, M.

AU - Pupilli, C.

AU - Opocher, G.

AU - Valenza, T.

AU - Baldi, E.

AU - Serio, M.

PY - 1987

Y1 - 1987

N2 - In the present paper we report our experience on the utility of basal plasma catecholamine (CA) measurement and of the clonidine-suppression test in the diagnosis of pheochromocytoma. Basal noradrenaline (NA) and adrenaline (A) were assayed in plasma samples of 27 subjects affected by pheochromocytoma. When compared to basal values obtained in hypertensive patients without pheochromocytoma, one or both the CA resulted pathologically elevated in all patients except one. The response to the clonidine-suppression test was evaluated in 41 hypertensive patients suspected of having a pheochromocytoma measuring plasma NA and A in basal conditions and 2 and 3 h after oral administration of 300 μg clonidine. Extensive laboratory and instrumental findings confirmed the presence of pheochromocytoma only in 12 patients. Among the other 29 patients basal plasma CA resulted higher than normal in 4 patients. In patients without pheochromocytoma clonidine induced a significant fall in both NA and A plasma levels. The decrease in NA was observed in each patient. The 12 patients with pheochromocytoma showed a pathological elevation of one or both the CA. In this group clonidine did not significantly suppress plasma CA. The individual responses were extremely variable. Our data confirm the validity of plasma CA measurement as a diagnostic tool for the diagnosis of pheochromocytoma. The results of the clonidine-suppression test were generally confirmatory of the basal CA plasma values but in the 4 hypertensive patients without pheochromocytoma who showed basal plasma CA higher than normal clonidine resulted a useful tool in excluding the presence of pheochromocytoma.

AB - In the present paper we report our experience on the utility of basal plasma catecholamine (CA) measurement and of the clonidine-suppression test in the diagnosis of pheochromocytoma. Basal noradrenaline (NA) and adrenaline (A) were assayed in plasma samples of 27 subjects affected by pheochromocytoma. When compared to basal values obtained in hypertensive patients without pheochromocytoma, one or both the CA resulted pathologically elevated in all patients except one. The response to the clonidine-suppression test was evaluated in 41 hypertensive patients suspected of having a pheochromocytoma measuring plasma NA and A in basal conditions and 2 and 3 h after oral administration of 300 μg clonidine. Extensive laboratory and instrumental findings confirmed the presence of pheochromocytoma only in 12 patients. Among the other 29 patients basal plasma CA resulted higher than normal in 4 patients. In patients without pheochromocytoma clonidine induced a significant fall in both NA and A plasma levels. The decrease in NA was observed in each patient. The 12 patients with pheochromocytoma showed a pathological elevation of one or both the CA. In this group clonidine did not significantly suppress plasma CA. The individual responses were extremely variable. Our data confirm the validity of plasma CA measurement as a diagnostic tool for the diagnosis of pheochromocytoma. The results of the clonidine-suppression test were generally confirmatory of the basal CA plasma values but in the 4 hypertensive patients without pheochromocytoma who showed basal plasma CA higher than normal clonidine resulted a useful tool in excluding the presence of pheochromocytoma.

KW - clonidine-suppression test

KW - Pheochromocytoma

KW - plasma catecholamines

KW - urinary vanillylmandelic acid

UR - http://www.scopus.com/inward/record.url?scp=0023390444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023390444&partnerID=8YFLogxK

U2 - 10.1007/BF03348153

DO - 10.1007/BF03348153

M3 - Article

C2 - 2890684

AN - SCOPUS:0023390444

VL - 10

SP - 377

EP - 382

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 4

ER -